Pharmacokinetics, pharmacodynamics, and tolerability of clevidipine in patients with mild to moderate essential hypertension

Trial Profile

Pharmacokinetics, pharmacodynamics, and tolerability of clevidipine in patients with mild to moderate essential hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Clevidipine (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top